296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

P131

2-year real-world outcomes�from the use of Faricimab in neovascular�age-related macular degeneration resistant to other anti-vascular endothelial growth factors.

Preview of 2-year real-world outcomes�from the use of Faricimab in neovascular�age-related macular degeneration resistant to other anti-vascular endothelial growth factors.

View Poster Contact Presenter

Poster Presenter

Eslam Ahmed

Authors

Eslam Ahmed, Christine Goodchild, Anastasios Bisoukis, Serena Salvatore

Part of Topic

Medical retina

Two-year real-world outcomes from the use of faricimab in neovascular age-related macular degeneration resistant to other anti-vascular endothelial growth factors

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.